background image

Paid Clinical Trials Orlando

Discover 973 paid clinical trials in Orlando, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1
PHASE2

Sponsor:

Moderna

Location:

Orlando FL, Tampa FL, Jacksonville FL, Doral FLshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

Recruiting
PHASE2

Sponsor:

Pfizer

Location:

Orlando FL, Windermere FL, Kissimmee FL, Atlanta GAshow 14 more

Code:

NCT05287126

Conditions

Ulcerative Colitis

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Etrasimod

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

Recruiting

Sponsor:

AbbVie

Location:

Orlando FL, Canton OH, Commack NY, Chicago ILshow 8 more

Code:

NCT06107426

Conditions

Parkinson's Disease (PD)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis

Recruiting
PHASE2

Sponsor:

Immunovant Sciences GmbH

Location:

Winter Park FL, Zephyrhills FL, Jupiter FL, Miami FLshow 17 more

Code:

NCT06754462

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

IMVT-1402

Placebo

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Recruiting
PHASE1
PHASE2

Sponsor:

Iovance Biotherapeutics, Inc.

Location:

Orlando FL, Tampa FL, Miami FL, Louisville KYshow 6 more

Code:

NCT05361174

Conditions

Unresectable Melanoma

Metastatic Melanoma

Stage III Non-small Cell Lung Cancer

Stage IV Non-small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

IOV-4001

A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

Recruiting

Sponsor:

Theratechnologies

Location:

Orlando FL, Tampa FL, West Palm Beach FL, Fort Lauderdale FLshow 21 more

Code:

NCT05388474

Conditions

HIV Infections

Multi-Antiviral Resistance

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

No ibalizumab or Pre-ibalizumab treatment

On ibalizumab treatment

Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants

Recruiting

Sponsor:

Nationwide Children's Hospital

Location:

Orlando FL, Hollywood FL, Nashville TN, Memphis TNshow 17 more

Code:

NCT05547165

Conditions

Ductus Arteriosus, Patent

Eligibility Criteria

Sex: All

Age: 7 - 32

Healthy Volunteers: Not accepted

Interventions

Percutaneous Patent Ductus Arteriosus Closure (PPC)

Responsive Management Intervention

Echocardiogram, cardiac

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

Recruiting

Sponsor:

Nicole Hamblett

Location:

Orlando FL, Tampa FL, Gainesville FL, Miami FLshow 58 more

Code:

NCT06504589

Conditions

Cystic Fibrosis

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC

Recruiting
PHASE3

Sponsor:

Shanghai Henlius Biotech

Location:

Clermont FL, Orange City FL, Brooksville FL, Ocala FLshow 85 more

Code:

NCT05468489

Conditions

Extensive Stage Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Serplulimab + chemotherapy (carboplatin-etoposide)

Atezolizumab + chemotherapy (carboplatin-etoposide)

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting
PHASE3

Sponsor:

NRG Oncology

Location:

Orlando FL, Ocoee FL, Lake Mary FL, Gainesville FLshow 706 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Recruiting
PHASE1

Sponsor:

Conjupro Biotherapeutics, Inc.

Location:

Celebration FL, Sarasota FL, Nashville TN, Fairfax VAshow 9 more

Code:

NCT05948865

Conditions

Cancer

Cancer, Lung

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CPO301

Orlando, Florida has a well-developed healthcare system with several prominent medical research facilities, making it an important hub for a diverse array of clinical trials. Notable institutions such as the Orlando Health Cancer Institute and the University of Central Florida's College of Medicine are at the forefront of these research initiatives.

Each medical center in Orlando focuses on innovative studies across various fields, including oncology, cardiovascular health, and neurological disorders, positioning Orlando as a vital contributor in advancing medical research and treatment options.

Why choose Orlando for clinical trials?

Common conditions studied in Orlando

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Orlando